Literature DB >> 14559750

Predicting incidence of variant Creutzfeldt-Jakob disease from UK dietary exposure to bovine spongiform encephalopathy for the 1940 to 1969 and post-1969 birth cohorts.

J D Cooper1, S M Bird.   

Abstract

BACKGROUND: To investigate variant Creutzfeldt-Jakob disease (vCJD) incubation period, transmission barrier, and short-term vCJD predictions for methionine homozygotes in 1940-1969 and post-1969 birth cohorts by use of gender- and age-specific exposure intensities to bovine spongiform encephalopathy (BSE), based on consumption of beef mechanically recovered meat (MRM) and head meat.
METHODS: Simulation (from vCJD infections generated randomly from gender and age-specific dietary exposure intensities to BSE), constrained to equal the 47 and 64 vCJD onsets before 2001 in 1940-1969 and post-1969 birth cohorts, was used to estimate lognormal (and other) incubation mean and standard deviation which fitted the calendar year distribution of observed vCJD onsets; and to explore exponential decay in susceptibility to infection with age above 15 years.
RESULTS: For the post-1969 birth cohort, the best-fitting lognormal incubation period mean of 11 years (SD 1.5 years and 195 infections) was associated with 194 vCJD onsets (64 before 2001, 105 in 2001-2005, and 25 in 2006-2010). About one-fifth of simulated vCJD onsets before 2001 arose from infections in 1990-1996; age and gender of simulated and observed vCJD patients agreed closely. For the 1940-1969 birth cohort, well-fitting lognormal means ranged widely, the marginally best fitting being 26 years (SD 16.5 years and 382 infections; 47 vCJD onsets before 2001, 58 in 2001-2005, and 63 in 2006-2010). An age-dependent susceptibility function was required to match the age distribution of vCJD patients in the 1940-1969 birth cohort.
CONCLUSIONS: About three-fifths of predicted vCJD onsets are expected to be in males, and nearly two-thirds of vCJD onsets in 2001-2005 are expected to be in post-1969 birth cohort according to best-fitting predictions.

Entities:  

Mesh:

Year:  2003        PMID: 14559750     DOI: 10.1093/ije/dyg248

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  6 in total

1.  Recipients of blood or blood products "at vCJD risk".

Authors:  Sheila M Bird
Journal:  BMJ       Date:  2004-01-17

Review 2.  American fresh frozen plasma for neonates and children.

Authors:  D R Norfolk; A Glaser; S Kinsey
Journal:  Arch Dis Child       Date:  2005-01       Impact factor: 3.791

3.  Projections of the future course of the primary vCJD epidemic in the UK: inclusion of subclinical infection and the possibility of wider genetic susceptibility.

Authors:  Paul Clarke; Azra C Ghani
Journal:  J R Soc Interface       Date:  2005-03-22       Impact factor: 4.118

Review 4.  Understanding Prion Strains: Evidence from Studies of the Disease Forms Affecting Humans.

Authors:  Marcello Rossi; Simone Baiardi; Piero Parchi
Journal:  Viruses       Date:  2019-03-29       Impact factor: 5.048

5.  Epidemiological evidence of higher susceptibility to vCJD in the young.

Authors:  Pierre-Yves Boëlle; Jean-Yves Cesbron; Alain-Jacques Valleron
Journal:  BMC Infect Dis       Date:  2004-08-10       Impact factor: 3.090

6.  Estimation of the exposure of the UK population to the bovine spongiform encephalopathy agent through dietary intake during the period 1980 to 1996.

Authors:  Chu-Chih Chen; Yin-Han Wang
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.